$ITGR

Integer Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR

Integer Holdings Corp (ITGR) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Integer Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR PLANO, Texas, September 30, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading global medical device contract

Original reporting
Published Sep 30, 2026, 12:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 12:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$ITGR
Bullish
high confidence
Mentioned
$ITGR
Relevance
9/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ITGRBullishHigh
01

Why it matters

The early termination of the HSR waiting period removes a key antitrust hurdle, increasing the probability of deal completion before year‑end and likely supporting Integer's share price.

02

Market read

First‑report filing confirming regulatory progress on a $5.7 B merger, a material catalyst for the target's stock.

03

What to watch

Potential financing constraints for KKR or integration challenges could delay or derail the transaction.

Relevance 9/10Novelty 9/10Timing: today

Background

Integer Holdings (NYSE: ITGR) is a leading medical‑device contract development and manufacturing organization. KKR announced a definitive agreement to acquire Integer for $127 per share, valuing the deal at about $5.7 B.

Company-level read

Ticker impact

$ITGRBullishHigh confidence
Context

Integer Holdings disclosed early termination of the HSR waiting period for its $5.7 B acquisition by KKR, removing a key regulatory hurdle.

Expected impact

upward pressure as investors price in the higher likelihood of deal completion

Evidence & confidence

The filing is the first public confirmation that the HSR waiting period has been terminated, a material step that reduces deal risk and typically triggers buying in the target's shares.

Market effects

The CDMO sector may see increased M&A activity as the deal validates consolidation trends.

U.S. healthcare and medical device investors may adjust exposure to merger‑related stocks.

The deal underscores continued private‑equity interest in global medical‑device manufacturing.

Counterpoint

If regulatory or shareholder approvals stall, the stock could face downside despite the HSR clearance.

Key entities

  • Integer Holdings Corp

    Target of the acquisition, ticker ITGR.

  • KKR

    Acquirer, affiliate of KKR funds.

Related articles

$KKRHighAI 8/10

KKR Secures $2.1B Loan for Integer Buyout

KKR secured a $2.1B loan for its $5.7B acquisition of Integer, with strong investor demand tightening terms. The loan was priced at 2.5% over benchmark, up to 0.5% tighter than initial discussions. Citigroup led the sale. Bloomberg data shows limited LBO financing this year, driving high demand. KKR aims to complete the Integer buyout by year-end, signaling robust credit market activity.

$KKRHighAI 8/10

KKR finalizes $2.1 billion loan to fund Integer acquisition

KKR & Co. (KKR) secured a $2.1 billion loan to finance its $5.7 billion acquisition of Integer Holdings (ITGR), with improved borrowing terms due to strong investor demand. The loan was priced at 2.5 percentage points above its benchmark, lower than initially discussed. The transaction is expected to close by the end of 2026, with Citigroup (C) leading the loan sale. KKR shares fell 1.9% on Friday, while Integer shares remained unchanged.

$ITGRHighAI 9/10

How Could KKR's $5.7 Billion Buyout Reshape ITGR for Shareholders?

Integer Holdings (ITGR) agreed to a $5.7B buyout by KKR, offering $127 per share. The deal's completion depends on shareholder and regulatory approvals. ITGR withdrew its financial outlook and canceled its Q2 earnings call. If completed, ITGR will become private and delist from NYSE. ITGR's Q2 sales fell 2.6% YoY to $464.1M, with gross margin contracting to 24.3%.

$ITGRHighAI 9/10

51.8% premium on table in KKR deal for Integer (NYSE: ITGR), if shareholders approve

KKR-affiliated entities plan to acquire Integer Holdings (ITGR) for $127 per share, a 51.8% premium over the unaffected closing price. The deal requires shareholder approval and regulatory clearances. ITGR's board recommends voting in favor, with completion subject to customary conditions. If approved, ITGR will become a subsidiary of the buyer and cease trading on NYSE.

$ITGRHighAI 9/10

What Integer's Deal Means for Minnesota's Med Device Industry

Integer Holdings, a major medical device manufacturer, is being acquired by KKR for $5.7B. Integer supplies components to companies like Abbott, Boston Scientific, and Medtronic. The deal may impact Minnesota's med-tech industry, where Integer has significant operations. KKR's acquisition could lead to consolidation in the sector, with potential implications for competition and pricing. Integer reported $1.8B in revenue last year.